Azitra, Inc. Regains Compliance with NYSE American Continued Listing Standards

RegulatoryPositive

AI Analysis

Summary

Azitra, Inc. announced it has regained compliance with NYSE American continued listing standards. The company is a clinical stage biopharmaceutical company focused on precision dermatology and cosmetic protein and peptide therapies.

Outcome Details

Regained compliance with NYSE American continued listing standards

Importance:3/10

Sentiment:

0.60

compliancelisting standardsNYSE Americandermatologycosmetic proteinspeptides

Related Companies

$AZTR

Read the original article

Published by PR Newswire Biotech on August 21, 2026 12:00 PM

Read Original